vorapaxar
Selected indexed studies
- Vorapaxar. (, 2012) [PMID:31644210]
- Vorapaxar. (Am J Cardiovasc Drugs, 2010) [PMID:21090833]
- Vorapaxar enhanced mitochondria-associated ferroptosis primes cancer immunotherapy via targeting FOXO1/HMOX1 axis. (Cell Rep Med, 2025) [PMID:41005298]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Vorapaxar. (2012) pubmed
- Vorapaxar. (2010) pubmed
- Vorapaxar enhanced mitochondria-associated ferroptosis primes cancer immunotherapy via targeting FOXO1/HMOX1 axis. (2025) pubmed
- Vorapaxar for Prevention of Major Adverse Cardiovascular and Limb Events in Peripheral Artery Disease. (2022) pubmed
- Vorapaxar and Amyotrophic Lateral Sclerosis: Coincidence or Adverse Association? (2017) pubmed
- Vorapaxar in the secondary prevention of atherothrombosis. (2015) pubmed
- Vorapaxar and diplopia: Possible off-target PAR-receptor mismodulation. (2016) pubmed
- Vorapaxar: first global approval. (2014) pubmed
- Vorapaxar, a Protease-Activated Receptor-1 Antagonist, a Double-Edged Sword! (2014) pubmed
- Vorapaxar in atherosclerotic disease management. (2015) pubmed